Ntafoulis I, Kleijn A, Ju J, Jimenez-Cowell K, et al. Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers. Br J Cancer 2023 Aug 24. doi: 10.1038/s41416-023-02402.
PMID: 37620410